01:23

Visualizing Radiological Data Bias with Persistence Images | Oncotarget

01:08

Persistence Barcodes: Reducing Bias in Radiological Analysis | Oncotarget

04:32

Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC | Oncotarget

01:02

Reducing Bias in Radiology with Topological Data Analysis | Oncotarget

02:00

Extracellular Matrix and Tumor-Immune Interactions: Challenges & Opportunities | Oncotarget

01:31

Navigating Bias in AI-Driven Cancer Detection | Oncotarget

02:33

Precision Medicine in SCLC: DLL3, ASC1, TTF-1, and Ki-67 Expression | Oncotarget

01:45

Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer | Oncotarget

02:02

Tumor Dormancy Initiated by Lymphovascular Embolus | Oncotarget

01:02

Complete Response to Encorafenib + Binimetinib in BRAF V600E-Mutant Tumor | Oncotarget

06:16

Behind the Study: Molecular Chaperones & Tumor Suppressor Stability | Oncotarget

02:04

How Blood Cancer Cells Rewire to Evade Drug Treatment | Oncotarget

01:30

Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget

01:45

Molecular Chaperones: Guardians of Tumor Suppressor Stability | Oncotarget

01:48

TP53 Mutated AML: Transplant or No Transplant | Oncotarget

02:34

Zika Virus as a Treatment for Brain Cancer: A Systematic Review | Oncotarget

01:33

Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy | Oncotarget

01:57

UBA1 Dysfunction in VEXAS and Cancer | Oncotarget

01:44

FOXM1 and PD-L1 in CDK4/6-MEK Resistance in Nerve Tumors | Oncotarget

01:42

AI's Role in Advancing Intratumoral Immunotherapy | Oncotarget

02:13

ISR Activation & Apoptosis via HRI Kinase by PG3 and Other p53 Cancer Therapies | Oncotarget

01:34

Targeting CD47/SIRPα 'Do Not Eat Me' Axis: Advances and Challenges in Cancer Therapy | Oncotarget

01:38

Next-Gen Vaccines Offer New Hope Against Glioblastoma | Oncotarget

01:05

Generative AI in Cancer Imaging: Revolutionizing Detection & Diagnosis | Oncotarget

01:45

Case for Inflammatory Memory for Hematopoietic Stem and Progenitor Cells in AML Niche | Oncotarget

01:05

Targeting WNT5B and WNT10B in Osteosarcoma | Oncotarget

01:08

Graph Filtration Learning Reveals New Dimensions in Hepatocellular Carcinoma Imaging | Oncotarget

02:01

miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer | Oncotarget

01:13

Artificial Intelligence: Revolutionizing Precision Oncology | Oncotarget

01:27

Genotype Matters: Tailored Screening for Germline CHEK2 Variants | Oncotarget

01:39

Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity | Oncotarget

01:21

Gut Barrier as Gatekeeper in Colorectal Cancer Treatment | Oncotarget

01:26

Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice | Oncotarget

02:42

Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors | Oncotarget

01:35

New Directions in Targeting the Multifaceted BRAF in Cancer | Oncotarget

01:52

CDR3s and Renalase-1 Correlate with Increased Melanoma Survival | Oncotarget

00:58

How to Deal with Runaway Metastatic Disease? | Oncotarget

02:06

INT-1B3 miR-193a-3p Mimic Boosts T Cell Anti-Tumor Response | Oncotarget

02:06

Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis | Oncotarget

01:56

Prognostic and Therapeutic Insights into MIF, DDT, and CD74 in Melanoma | Oncotarget

02:39

Enhanced Pembrolizumab Efficacy with EphB4-Albumin in HPV-Negative Head and Neck Cancer | Oncotarget

01:28

DDX41 and its Unique Contribution to Myeloid Leukemogenesis | Oncotarget

01:38

Early ctDNA as Response Assessment in Metastatic Prostate Cancer | Oncotarget

01:32

HER2-Low and HER2-Zero in Breast Cancer: Prognosis & Prediction | Oncotarget

02:44

FDG-PET/CT vs. CT for Tumor Response to Nivolumab Plus Ipilimumab in Mesothelioma | Oncotarget

01:46

Targeting ABC Transporters in PDAC – Past, Present or Future? | Oncotarget

02:33

Regorafenib and TAS102 Synergize Against Gastrointestinal Cancers | Oncotarget

01:27

Genomics Has More to Reveal | Oncotarget

01:36

Enhancing DNA Damage and Immunotherapy by Starving Cancer Cells | Oncotarget

01:46

Leveraging Gold Nanostars for Precision Laser Interstitial Thermal Therapy | Oncotarget

01:56

Serum Tumor Markers in NSCLC Management | Oncotarget

01:31

When Does Melanoma Metastasize? Implications for Management | Oncotarget

01:02

Impact Journals (Oncotarget's Publisher) Sponsors 2024 Ride for Roswell | Oncotarget

02:12

Synergistic Effects of HDAC, PARP Inhibitors, and Decitabine in Pancreatic Cancer | Oncotarget

01:41

BTK Inhibitor-Related Cardiotoxicity: Predictive Biomarkers and Risk Stratification | Oncotarget

06:47

Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget

02:00

Importance of Integrated Therapies on Cancer: Silibinin, an Old and New Molecule | Oncotarget

02:16

GZ17-6.02 Kills PDX Isolates of Uveal Melanoma | Oncotarget

02:10

Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget

01:34

Cyclin D1 Expression in Penile Cancer | Oncotarget